StockData
ImageneBio, Inc. logo

ImageneBio, Inc. (IMA) stock

IMANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 6/30
$3.20−0.27 (-7.78%)

Close on Nov 16, 2026Market cap $36.32MP/E –Yield –

ImageneBio market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

ImageneBio's market cap was $39.04M on Nov 11, 2026, against $106.72M a year earlier. Over the last 5 years it ranged from $24.35M to $5.40B, with a median of $970.29M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$39.04M-63.4%
2025Dec 31, 2025$106.72M-88.8%
2024Dec 31, 2024$949.76M-8.9%
2023Dec 29, 2023$1.04B-9.9%
2022Dec 30, 2022$1.16B-78.6%
2021Dec 31, 2021$5.40B–

More ImageneBio figures

See a number that looks wrong?